...
首页> 外文期刊>Infection and immunity >Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.
【24h】

Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.

机译:来自新隐球菌血清型A菌株的纯化和放射性碘标记的荚膜多糖与无胶囊突变体的结合。

获取原文
           

摘要

Strains 6, 15, 98, 110, and 145 of Cryptococcus neoformans serotype A vary in capsule size, animal virulence, and susceptibility to in vitro phagocytosis. The isolated capsular polysaccharides (CPSs) differ in monosaccharide composition ratios and molecular size, as determined by gel filtration. The purpose of this investigation was to characterize the binding of CPSs to capsule-free mutants of C. neoformans and to examine CPSs from these strains for differences in their ability to bind, to determine whether such differences might explain the variation in the pathobiology of these strains. CPSs were partially periodate oxidized, tyraminated, iodinated with 125I, and used in binding studies with two capsule-free mutants of C. neoformans, strain 602 and Cap59. Binding was specific for yeast species and for polysaccharide and was saturable, which is consistent with a receptor-mediated mechanism of attachment. Binding occurred rapidly and was only slowly reversible. Binding was also independent of pH from pH 5.5 to 8, of cation concentrations, and of competition by sugars up to 1.0 M concentrations. Only a portion of CPS was capable of binding, and strains varied in the extent to which their CPS bound. CPS-15-IV (peak IV was the major polysaccharide peak on DEAE-cellulose chromatography of CPS from strain 15) had the highest proportion of binding (40%), followed by CPS from strains 98, 6, 145, 110, and 15-III (peak III was an earlier eluting fraction of CPS from strain 15). The CPSs differed similarly in their ability to competitively inhibit binding. Treatment of CPS, but not yeast cells, with proteinase XIV abolished binding without altering the CPS gross structure. Treatment of yeast cells with proteases, heat, or formaldehyde did not alter binding, and both strain 602 and Cap59 bound CPS similarly. Binding to encapsulated yeast cells was minimal.
机译:新型隐球菌血清型A的菌株6、15、98、110和145在胶囊大小,动物毒力和对体外吞噬作用的敏感性方面有所不同。分离的荚膜多糖(CPS)的单糖组成比和分子大小有所不同,这是通过凝胶过滤确定的。这项研究的目的是表征CPS与新形成梭菌的无胶囊突变体的结合,并检查这些菌株中CPS的结合能力差异,以确定这些差异是否可以解释它们的病理生物学差异。株。 CPS被部分高碘酸盐氧化,酪氨酸化,并用125 I碘化,并用于与两个无荚膜梭状芽孢杆菌突变株602和Cap59的结合研究。结合对于酵母物种和多糖是特异性的,并且是饱和的,这与受体介导的附着机制一致。结合迅速发生并且仅缓慢可逆。结合也不受pH 5.5至8的pH,阳离子浓度和糖浓度高达1.0 M的竞争的影响。只有一部分CPS能够结合,并且菌株的CPS结合程度有所不同。 CPS-15-IV(峰值IV是来自菌株15的CPS的DEAE-纤维素色谱上的主要多糖峰)的结合比例最高(40%),其次是菌株98、6、145、110和15的CPS -III(峰值III是来自菌株15的CPS较早洗脱的馏分)。 CPS在竞争性抑制结合的能力方面也类似。用蛋白酶XIV处理CPS而非酵母细胞可消除结合,而不会改变CPS的总体结构。用蛋白酶,加热或甲醛处理酵母细胞不会改变结合,并且菌株602和Cap59都类似地结合CPS。与封装的酵母细胞的结合极少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号